Remission vs. Regulation: Discussing Options for Patients with Type 2 Diabetes (EACCME)

EU

$0

free

EACCME

1 hr

Cardiovascular, Diabetes, Endocrinology

1 Credits

Course Description

Recent evidence regarding diabetes remission has increased the number of options for patients with type 2 diabetes. In addition to reviewing the evidence for remission of type 2 diabetes, this module will discuss guideline recommendations for initiating therapy in patients with type 2 diabetes. Using a patient case, the module will provide clinicians with an example for how to engage patients in shared decision making and how to individualise treatment according to patient values, preferences, and priorities.


This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.

Course Details

Expiry Date: 2024-02-20

Professions: Specialist

Faculty

David Strain, BSc, MB. ChB., MRCP, MD, FRCP

Matthias Bluher, MD

Accreditation

This e-Learning material is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). You may claim a maximum of 1.0 hours (credits are automatically calculated).

Learning Objective(s)

Upon successful completion of this continuing education module, the participant will be better able to:

  • Discuss the evidence for remission of diabetes
  • Adjust or advance diabetes therapy in a timely manner according to local guidelines
  • Start a conversation with patients to enable shared decision making for treatment adjustments
  • Individualise treatment according to patient concerns and priorities.